Compare BFAM & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFAM | BLCO |
|---|---|---|
| Founded | 1986 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.0B |
| IPO Year | 1997 | 2022 |
| Metric | BFAM | BLCO |
|---|---|---|
| Price | $101.81 | $16.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $130.67 | $17.31 |
| AVG Volume (30 Days) | ★ 752.3K | 356.8K |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.95 | N/A |
| EPS | ★ 3.47 | N/A |
| Revenue | $2,874,055,000.00 | ★ $4,976,000,000.00 |
| Revenue This Year | $11.17 | $8.08 |
| Revenue Next Year | $6.93 | $5.77 |
| P/E Ratio | $29.33 | ★ N/A |
| Revenue Growth | ★ 9.38 | 6.23 |
| 52 Week Low | $91.49 | $10.45 |
| 52 Week High | $132.99 | $18.55 |
| Indicator | BFAM | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 59.90 |
| Support Level | $97.24 | $16.74 |
| Resistance Level | $105.57 | $17.33 |
| Average True Range (ATR) | 2.51 | 0.42 |
| MACD | 0.22 | -0.01 |
| Stochastic Oscillator | 52.80 | 45.80 |
Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.